Table of Contents
1. EXECUTIVE SUMMARY
1.1. Market Attractiveness Analysis
1.1.1. Global Pain Relief Medication Market, by Drug Class
1.1.2. Global Pain Relief Medication Market, by Indication
1.1.3. Global Pain Relief Medication Market, by Distribution Channel
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.5. Breakdown of Primary Respondents
3.6. Forecasting Techniques
3.7. Research Methodology for Market Size Estimation
3.7.1. Bottom-Up Approach
3.7.2. Top-Down Approach
3.8. Data Triangulation
3.9. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Porterโs Five Forces Analysis
5.1.1. Bargaining Power of Suppliers
5.1.2. Bargaining Power of Buyers
5.1.3. Threat of New Entrants
5.1.4. Threat of Substitutes
5.1.5. Intensity of Rivalry
5.2. Value Chain Analysis
5.2.1. R&D and Designing
5.2.2. Manufacturing
5.2.3. Distribution & Sales
5.2.4. Post Sales Services
6. GLOBAL PAIN RELIEF MEDICATION MARKET, BY DRUG CLASS
6.1. Overview
6.2. Nonsteroidal Anti-Inflammatory Drugs
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.3. Opioids
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.4. COX-2 Inhibitors
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.5. Others
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7. GLOBAL PAIN RELIEF MEDICATION MARKET, BY INDICATION
7.1. Overview
7.2. Cancer Pain
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.3. Neuropathic Pain
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.4. Musculoskeletal Pain
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.5. Inflammatory Conditions
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.6. Others
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8. GLOBAL PAIN RELIEF MEDICATION MARKET, BY DISTRIBUTION CHANNEL
8.1. Overview
8.2. Hospital and Retail Pharmacies
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8.3. Online Pharmacies
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
9. GLOBAL PAIN RELIEF MEDICATION MARKET, BY REGION
9.1. Overview
9.2. Americas
9.2.1. North America
9.2.1.1. US
9.2.1.2. Canada
9.2.2. Latin America
9.3. Europe
9.3.1. Western Europe
9.3.1.1. Germany
9.3.1.2. France
9.3.1.3. Italy
9.3.1.4. Spain
9.3.1.5. UK
9.3.1.6. Rest of Western Europe
9.3.2. Eastern Europe
9.4. Asia-Pacific
9.4.1. Japan
9.4.2. China
9.4.3. India
9.4.4. Australia
9.4.5. South Korea
9.4.6. Rest of Asia-Pacific
9.5. Middle East & Africa
9.5.1. Middle East
9.5.2. Africa
10. COMPANY LANDSCAPE
10.1. Overview
10.2. Competitor Dashboard
10.3. Major Growth Strategy in the Global Pain Relief Medication Market
10.4. Competitive Benchmarking
10.5. The Leading Player in terms of Number of Developments in the Global Pain Relief Medication Market
10.6. Key Developments & Growth Strategies
10.7. Major Players Financial Matrix & Market Ratio
11. COMPANY PROFILES
11.1. AbbVie Inc.
11.1.1. Company Overview
11.1.2. Products/Services Offered
11.1.3. Financial Overview
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.1.6. Key Strategies
11.2. Allergan PLC
11.3. Astellas Pharma Inc.
11.4. Bayer
11.5. AbbVie Inc. Idec
11.6. Boehringer Ingelheim International GmbH
11.7. Bristol-Myers Squibb
11.8. Eli Lilly and Company
11.9. GlaxoSmithKline
11.10. Mallinckrodt Pharmaceuticals
11.11. Pfizer, Inc.
11.12. Purdue Pharma
11.13. Sanofi
11.14. Teva Pharmaceutical Industries Ltd
11.15. Others
12. APPENDIX
12.1. References
12.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL PAIN RELIEF MEDICATION MARKET SYNOPSIS, 2020-2027
TABLE 2 GLOBAL PAIN RELIEF MEDICATION MARKET ESTIMATES & FORECAST, 2020-2027 (USD MILLION)
TABLE 3 GLOBAL PAIN RELIEF MEDICATION MARKET, BY DRUG CLASS, 2020-2027 (USD MILLION)
TABLE 4 GLOBAL PAIN RELIEF MEDICATION MARKET, BY INDICATION, 2020-2027 (USD MILLION)
TABLE 5 GLOBAL PAIN RELIEF MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
TABLE 6 GLOBAL PAIN RELIEF MEDICATION MARKET, BY REGION, 2020-2027 (USD MILLION)
TABLE 7 NORTH AMERICA: PAIN RELIEF MEDICATION MARKET, BY DRUG CLASS, 2020-2027 (USD MILLION)
TABLE 8 NORTH AMERICA: PAIN RELIEF MEDICATION MARKET, BY INDICATION, 2020-2027 (USD MILLION)
TABLE 9 NORTH AMERICA: PAIN RELIEF MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
TABLE 10 US: PAIN RELIEF MEDICATION MARKET, BY DRUG CLASS, 2020-2027 (USD MILLION)
TABLE 11 US: PAIN RELIEF MEDICATION MARKET, BY INDICATION, 2020-2027 (USD MILLION)
TABLE 12 US: PAIN RELIEF MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
TABLE 13 CANADA: PAIN RELIEF MEDICATION MARKET, BY DRUG CLASS, 2020-2027 (USD MILLION)
TABLE 14 CANADA: PAIN RELIEF MEDICATION MARKET, BY INDICATION, 2020-2027 (USD MILLION)
TABLE 15 CANADA: PAIN RELIEF MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
TABLE 16 LATIN AMERICA: PAIN RELIEF MEDICATION MARKET, BY DRUG CLASS, 2020-2027 (USD MILLION)
TABLE 17 LATIN AMERICA: PAIN RELIEF MEDICATION MARKET, BY INDICATION, 2020-2027 (USD MILLION)
TABLE 18 LATIN AMERICA: PAIN RELIEF MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
TABLE 19 EUROPE: PAIN RELIEF MEDICATION MARKET, BY DRUG CLASS, 2020-2027 (USD MILLION)
TABLE 20 EUROPE: PAIN RELIEF MEDICATION MARKET, BY INDICATION, 2020-2027 (USD MILLION)
TABLE 21 EUROPE: PAIN RELIEF MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
TABLE 22 WESTERN EUROPE: PAIN RELIEF MEDICATION MARKET, BY DRUG CLASS, 2020-2027 (USD MILLION)
TABLE 23 WESTERN EUROPE: PAIN RELIEF MEDICATION MARKET, BY INDICATION, 2020-2027 (USD MILLION)
TABLE 24 WESTERN EUROPE: PAIN RELIEF MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
TABLE 25 EASTERN EUROPE: PAIN RELIEF MEDICATION MARKET, BY DRUG CLASS, 2020-2027 (USD MILLION)
TABLE 26 EASTERN EUROPE: PAIN RELIEF MEDICATION MARKET, BY INDICATION, 2020-2027 (USD MILLION)
TABLE 27 EASTERN EUROPE: PAIN RELIEF MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
TABLE 28 ASIA-PACIFIC: PAIN RELIEF MEDICATION MARKET, BY DRUG CLASS, 2020-2027 (USD MILLION)
TABLE 29 ASIA-PACIFIC: PAIN RELIEF MEDICATION MARKET, BY INDICATION, 2020-2027 (USD MILLION)
TABLE 30 ASIA-PACIFIC: PAIN RELIEF MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
TABLE 31 MIDDLE EAST & AFRICA: PAIN RELIEF MEDICATION MARKET, BY DRUG CLASS, 2020-2027 (USD MILLION)
TABLE 32 MIDDLE EAST & AFRICA: PAIN RELIEF MEDICATION MARKET, BY INDICATION, 2020-2027 (USD MILLION)
TABLE 33 MIDDLE EAST & AFRICA: PAIN RELIEF MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL PAIN RELIEF MEDICATION MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL PAIN RELIEF MEDICATION MARKET
FIGURE 4 GLOBAL PAIN RELIEF MEDICATION MARKET SHARE, BY DRUG CLASS, 2020 (%)
FIGURE 5 GLOBAL PAIN RELIEF MEDICATION MARKET SHARE, BY INDICATION, 2020 (%)
FIGURE 6 GLOBAL PAIN RELIEF MEDICATION MARKET SHARE, BY DISTRIBUTION CHANNEL, 2020 (%)
FIGURE 7 GLOBAL PAIN RELIEF MEDICATION MARKET SHARE, BY REGION, 2020 (%)
FIGURE 8 AMERICAS: PAIN RELIEF MEDICATION MARKET SHARE BY REGION, 2020 (%)
FIGURE 9 NORTH AMERICA: PAIN RELIEF MEDICATION MARKET SHARE, BY COUNTRY, 2020 (%)
FIGURE 10 EUROPE: PAIN RELIEF MEDICATION MARKET SHARE, BY REGION, 2020 (%)
FIGURE 11 WESTERN EUROPE: PAIN RELIEF MEDICATION MARKET SHARE, BY COUNTRY, 2020 (%)
FIGURE 12 ASIA-PACIFIC: PAIN RELIEF MEDICATION MARKET SHARE, BY COUNTRY, 2020 (%)
FIGURE 13 MIDDLE EAST & AFRICA: PAIN RELIEF MEDICATION MARKET SHARE, BY COUNTRY, 2020 (%)
FIGURE 14 GLOBAL PAIN RELIEF MEDICATION MARKET: COMPANY SHARE ANALYSIS, 2020 (%)
FIGURE 15 ABBVIE INC.: KEY FINANCIALS
FIGURE 16 ABBVIE INC.: SEGMENTAL REVENUE
FIGURE 17 ABBVIE INC.: REGIONAL REVENUE
FIGURE 18 ALLERGAN PLC: KEY FINANCIALS
FIGURE 19 ALLERGAN PLC: SEGMENTAL REVENUE
FIGURE 20 ALLERGAN PLC: REGIONAL REVENUE
FIGURE 21 ASTELLAS PHARMA INC.: KEY FINANCIALS
FIGURE 22 ASTELLAS PHARMA INC.: SEGMENTAL REVENUE
FIGURE 23 ASTELLAS PHARMA INC.: REGIONAL REVENUE
FIGURE 24 BAYER: KEY FINANCIALS
FIGURE 25 BAYER: SEGMENTAL REVENUE
FIGURE 26 BAYER: REGIONAL REVENUE
FIGURE 27 BIOGEN IDEC: KEY FINANCIALS
FIGURE 28 BIOGEN IDEC: SEGMENTAL REVENUE
FIGURE 29 BIOGEN IDEC: REGIONAL REVENUE
FIGURE 30 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: KEY FINANCIALS
FIGURE 31 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: SEGMENTAL REVENUE
FIGURE 32 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: REGIONAL REVENUE
FIGURE 33 BRISTOL-MYERS SQUIBB: KEY FINANCIALS
FIGURE 34 BRISTOL-MYERS SQUIBB: SEGMENTAL REVENUE
FIGURE 35 BRISTOL-MYERS SQUIBB: REGIONAL REVENUE
FIGURE 36 ELI LILLY AND COMPANY: KEY FINANCIALS
FIGURE 37 ELI LILLY AND COMPANY: SEGMENTAL REVENUE
FIGURE 38 ELI LILLY AND COMPANY: REGIONAL REVENUE
FIGURE 39 GLAXOSMITHKLINE: KEY FINANCIALS
FIGURE 40 GLAXOSMITHKLINE: SEGMENTAL REVENUE
FIGURE 41 GLAXOSMITHKLINE: REGIONAL REVENUE
FIGURE 42 MALLINCKRODT PHARMACEUTICALS: KEY FINANCIALS
FIGURE 43 MALLINCKRODT PHARMACEUTICALS: SEGMENTAL REVENUE
FIGURE 44 MALLINCKRODT PHARMACEUTICALS: REGIONAL REVENUE
FIGURE 45 PFIZER, INC.: KEY FINANCIALS
FIGURE 46 PFIZER, INC.: SEGMENTAL REVENUE
FIGURE 47 PFIZER, INC.: REGIONAL REVENUE
FIGURE 48 PURDUE PHARMA: KEY FINANCIALS
FIGURE 49 PURDUE PHARMA: SEGMENTAL REVENUE
FIGURE 50 PURDUE PHARMA: REGIONAL REVENUE
FIGURE 51 SANOFI: KEY FINANCIALS
FIGURE 52 SANOFI: SEGMENTAL REVENUE
FIGURE 53 SANOFI: REGIONAL REVENUE
FIGURE 54 TEVA PHARMACEUTICAL INDUSTRIES LTD: KEY FINANCIALS
FIGURE 55 TEVA PHARMACEUTICAL INDUSTRIES LTD: SEGMENTAL REVENUE
FIGURE 56 TEVA PHARMACEUTICAL INDUSTRIES LTD: REGIONAL REVENUE